Vermont S0154 requires health insurance and Medicaid to cover biomarker testing for diagnosis, treatment, and monitoring of diseases.

Vermont S0154 mandates health insurance and Medicaid coverage for biomarker testing. Biomarker testing involves analyzing a patient's tissue, blood, or other biospecimen for biomarkers, which are indicators of biological processes or responses to therapeutic interventions. The coverage applies when supported by medical and scientific evidence, including FDA approvals, drug indications, and clinical practice guidelines. The Agency of Human Services must ensure Medicaid coverage without disrupting care, and may need to amend Vermont’s Medicaid state plan for compliance.

Vermont S0154 requires health insurance and Medicaid to cover biomarker testing for diagnosis, treatment, and monitoring of diseases.

Vermont S0154 mandates health insurance and Medicaid coverage for biomarker testing. Biomarker testing involves analyzing a patient's tissue, blood, or other biospecimen for biomarkers, which are indicators of biological processes or responses to therapeutic interventions. The coverage applies when supported by medical and scientific evidence, including FDA approvals, drug indications, and clinical practice guidelines. The Agency of Human Services must ensure Medicaid coverage without disrupting care, and may need to amend Vermont’s Medicaid state plan for compliance.